Novel Molecular Mechanism of Aspirin and Celecoxib Targeting Mammalian Neuraminidase-1 Impedes Epidermal Growth Factor Receptor Signaling Axis and Induces Apoptosis in Pancreatic Cancer Cells

BACKGROUND: Aspirin (acetylsalicylic acid) and celecoxib have been used as potential anti-cancer therapies. Aspirin exerts its therapeutic effect in both cyclooxygenase (COX)-dependent and -independent pathways to reduce tumor growth and disable tumorigenesis. Celecoxib, a selective cyclooxygenase-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Qorri, Bessi, Harless, William, Szewczuk, Myron R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550724/
https://www.ncbi.nlm.nih.gov/pubmed/33116404
http://dx.doi.org/10.2147/DDDT.S264122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550724/
https://www.ncbi.nlm.nih.gov/pubmed/33116404
http://dx.doi.org/10.2147/DDDT.S264122

Ejemplares similares